SCHEMBL14384674

SCHEMBL14384674

CC1(C)CC=C(c2cc(C3(C#N)CC4(C)CC[C@](C)(C3)O4)ccc2NC(=O)c2nc(C#N)c[nH]2)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16167959 1.00 — —
SCHEMBL14375016 0.93 — —
SCHEMBL14375015 0.92 — —
SCHEMBL14383673 0.91 CSF1R (0.54) —
SCHEMBL14383756 0.89 CSF1R (0.52) —
SCHEMBL14375005 0.88 CSF1R (0.53) —
SCHEMBL14375007 0.87 — —
SCHEMBL13877978 0.85 — —
SCHEMBL4238082 0.85 — —
SCHEMBL14383741 0.85 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007124319-A1 INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2007-11-01 — — WO disclosed
US-20070249680-A1 INHIBITORS OF C-FMS KINASE JANSSEN PHARMACEUTICA, N.V. (BE) 2007-10-25 — — US disclosed
Send feedback